[{"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0197-2023", "product_description": "Ceftazidime Intravitreal (1ML vial) 22.5 MG/ML(2.25MG/0.1ML) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221028@11", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0149-2023", "product_description": "Olopatadine HCl Ophthalmic Solution, USP 0.2%, 2.5 mL per bottle, Rx Only, Manufactured by:  Akorn, Inc., Lake Forest, IL 60045.  NDC:  17478-305-12", "product_quantity": "173,928 bottles", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: 0L48A, EXP 10/31/2022; 0L55A, EXP 10/31/2022; 1C75A, EXP 2/28/2023; 1E18A,  1E20A , EXP 4/30/2023;"}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92376", "recalling_firm": "Sagent Pharmaceuticals Inc", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0764-2023", "product_description": "Nafcillin for Injection, USP, 10 gram per Pharmacy Bulk Package, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.  NDC:  25021-141-99", "product_quantity": "370,200 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230519", "center_classification_date": "20230523", "report_date": "20230531", "code_info": "Lot: NFT101, EXP: 5/31/2024; Lots: NFT201, NFT202, EXP: 2/28/2025; Lots: NFT203, NFT204, EXP: 5/31/2025"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0155-2023", "product_description": "Sodium Chloride Ophthalmic Ointment, USP, 5%, Net Wt. 3.5 g (1/8 oz.) per tube,  Manufactured by:  Akorn, Inc., Lake Forest, IL 60045. NDC:  17478-622-35", "product_quantity": "524,506 tubes", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: 0F69A, EXP 5/31/2023; 0G92B, 0G92A, EXP 6/30/2023; 0J69A, EXP 8/31/2023; 0K29A, 0K24A, EXP 9/30/2023; 0M93A, 0M92A, 0M92B, EXP 11/30/2023; 1B25A, EXP 1/31/2024; 1C74A, EXP 2/29/2024; 1E19A, EXP 4/30/2024; 1C77A, EXP 2/29/2024;"}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1159-2023", "product_description": "TRP Natural Eyes, Floaters Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-098-15.", "product_quantity": "18,171 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: DA001 EXP: 06/24; Lot: DA002 EXP: 11/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209167"], "brand_name": ["TADALAFIL"], "generic_name": ["TADALAFIL"], "manufacturer_name": ["Northwind Pharmaceuticals, LLC"], "product_ndc": ["51655-473"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TADALAFIL"], "rxcui": ["402019"], "spl_id": ["29f19810-bb83-bacd-e063-6394a90a97ce"], "spl_set_id": ["f3092f5a-b976-91ab-e053-2995a90a9b50"], "package_ndc": ["51655-473-54", "51655-473-87"], "original_packager_product_ndc": ["16729-372"], "nui": ["N0000175599", "N0000020026"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "unii": ["742SXX0ICT"]}, "product_type": "Drugs", "event_id": "91944", "recalling_firm": "Northwind Pharmaceuticals LLC", "address_1": "4838 Fletcher Ave Ste 1000", "address_2": "N/A", "postal_code": "46203-1642", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0553-2023", "product_description": "Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.", "product_quantity": "a)164 bottles; b) 198 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230316", "center_classification_date": "20230426", "report_date": "20230503", "code_info": "a) Lot #: F113892002, Exp. Date 08/31/2023; F113892201, Exp. Date 11/30/2023 b) Lot #: F113892001, Exp. Date 08/31/2023; F113892202, Exp. Date 11/30/2023; F113892203, Exp. Date 12/31/2023"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "92249", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0756-2023", "product_description": "Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue Injection Only, Not for Intravenous Use, 1 mL Single Dose Vial, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Parenteral Unit, Ahmedabad 382213, India, Amneal Pharamceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1574-01.", "product_quantity": "69,239 vials", "reason_for_recall": "Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number 70121-1574-1.", "recall_initiation_date": "20230508", "center_classification_date": "20230519", "termination_date": "20240321", "report_date": "20230531", "code_info": "Lot Numbers: AP220481, Exp 09/2024; AP220536A, Exp 10/2024"}, {"status": "Completed", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022006"], "brand_name": ["SABRIL"], "generic_name": ["VIGABATRIN"], "manufacturer_name": ["Lundbeck Pharmaceuticals LLC"], "product_ndc": ["67386-211"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VIGABATRIN"], "spl_id": ["70fa5544-3c5c-4401-98c6-dbb992b6a198"], "spl_set_id": ["a88ac1b4-e2c9-45c0-b321-4785902172e3"], "package_ndc": ["67386-211-65"], "is_original_packager": [true], "nui": ["N0000175753"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "unii": ["GR120KRT6K"]}, "product_type": "Drugs", "event_id": "92894", "recalling_firm": "Lundbeck LLC", "address_1": "6 Parkway North Blvd Ste 400", "address_2": "N/A", "postal_code": "60015-2522", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S.", "recall_number": "D-1142-2023", "product_description": "Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65", "product_quantity": "10,543 cartons", "reason_for_recall": "Cross contamination with other products", "recall_initiation_date": "20230817", "center_classification_date": "20230829", "report_date": "20230906", "code_info": "Lot#: 3207333A, 3207334A, Exp 03/2027; 3214707A, 3214709A, 3214710A, Exp 02/2028 ."}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0198-2023", "product_description": "Cholecalciferol (Vitamin D3) 100,000U/ML Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221130@14", "more_code_info": ""}, {"status": "Terminated", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91786", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0460-2023", "product_description": "Alprazolam Tablets, USP, 1 mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0706-01), b) 500-count bottle (NDC 51991-0706-05) and c) 1,000-count bottle (NDC 51991-0706-10), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Potential risk of Cross Contamination", "recall_initiation_date": "20230302", "center_classification_date": "20230310", "termination_date": "20240321", "report_date": "20230322", "code_info": "Lot # 5210645, exp. date 3/31/2023, 500's Bottle 5210646, exp. date 3/31/2023, 500's Bottle 5210647, exp. date 3/31/2023, 500's Bottle  5210648, exp. date 3/31/2023, 1000's Bottle 5210649, exp. date 3/31/2023, 1000's Bottle  5210831, exp. date 4/30/2023, 100's Bottle  5210832, exp. date 4/30/2023, 500's Bottle 5210833, exp. date 4/30/2023, 500's Bottle  5210834, exp. date 4/30/2023, 1000's Bottle 5210835, exp. date 4/30/2023, 1000's Bottle  5210905, exp. date 5/31/2023, 100's Bottle 5210906, exp. date 5/31/2023, 100's Bottle  5210907, exp. date 5/31/2023, 500's Bottle 5210908, exp. date 5/31/2023, 500's Bottle 5210909, exp. date 5/31/2023, 500's Bottle 5210965, exp. date 5/31/2023, 500's Bottle  5210997, exp. date 5/31/2023, 1000's Bottle 5210998, exp. date 5/31/2023, 1000's Bottle 5211175, exp. date 6/30/2023, 1000's Bottle  5211176, exp. date 6/30/2023, 500's Bottle 5211177, exp. date 6/30/2023, 500's Bottle 5211178, exp. date 6/30/2023, 500's Bottle 5211179, exp. date 6/30/2023, 500's Bottle 5211180, exp. date 6/30/2023, 500's Bottle 5211181, exp. date 6/30/2023, 500's Bottle 5211205, exp. date 7/31/2023, 500 s Bottle 5211206, exp. date 7/31/2023, 500's Bottle  5211227, exp. date 7/31/2023, 1000's Bottle  5211228, exp. date 7/31/2023, 100's Bottle  5211229, exp. date 7/31/2023, 1000's Bottle  5211334, exp. date 8/31/2024, 500's Bottle  5211335, exp. date 8/31/2024, 1000's Bottle  5211456, exp. date 8/31/2024 , 500's Bottle 5211457, exp. date 8/31/2024 , 500's Bottle 5211458, exp. date 8/31/2024, 500's Bottle  5211459, exp. date 9/30/2024, 1000's Bottle  5211727, exp. date 11/30/2024, 100's Bottle  5211730, exp. date 11/30/2024, 1000's Bottle 5220028, exp. date 12/31/2024, 1000's Bottle 5220029, exp. date 12/31/2024, 1000's Bottle  5220288, exp. date 2/28/2025, 100's Bottle"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075356"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0083", "60505-0097", "60505-0084", "60505-0101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["9cde2ef4-fd50-ed21-0628-cb6cd8a6153f"], "spl_set_id": ["08320ea3-8f93-6f04-5d1c-f69af3eb5a81"], "package_ndc": ["60505-0097-1", "60505-0097-9", "60505-0097-2", "60505-0097-4", "60505-0097-7", "60505-0097-5", "60505-0083-1", "60505-0083-9", "60505-0083-2", "60505-0083-4", "60505-0083-0", "60505-0083-5", "60505-0084-1", "60505-0084-9", "60505-0084-2", "60505-0084-4", "60505-0084-5", "60505-0101-1", "60505-0101-9", "60505-0101-2", "60505-0101-4", "60505-0101-5", "60505-0101-7"], "is_original_packager": [true], "upc": ["0360505010110", "0360505008414", "0360505009718", "0360505008315"], "unii": ["3I3T11UD2S"]}, "product_type": "Drugs", "event_id": "93353", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0119-2024", "product_description": "Paroxetine Hydrochloride Tablets USP, RX only, 10 mg   a) 30-count bottle, NDC#: 60505-0097-1; b) 100-count bottle, NDC#: 60505-0097-2; c) 1000-count bottle, NDC#: 60505-0097-4, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.", "product_quantity": "34,392", "reason_for_recall": "Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine", "recall_initiation_date": "20231101", "center_classification_date": "20231127", "report_date": "20231206", "code_info": "Lot numbers: a)100 count bottle: RV2376, RV2377; b) 1000 count bottle: RV2379, RV2380; c) 30 count bottle: RV2375; Exp. 08/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0825-2023", "product_description": "Lorazepam Injection, USP  2 mg/mL vial, 1 mL vials, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0203-2023", "product_description": "Edetate Calcium Disodium 400MG/ML (30ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221013@15", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090935"], "brand_name": ["WARFARIN SODIUM"], "generic_name": ["WARFARIN SODIUM"], "manufacturer_name": ["Rising Health, LLC"], "product_ndc": ["57237-119", "57237-120", "57237-121", "57237-122", "57237-123", "57237-124", "57237-125", "57237-126", "57237-127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["WARFARIN SODIUM"], "rxcui": ["855288", "855296", "855302", "855312", "855318", "855324", "855332", "855338", "855344"], "spl_id": ["bab28da8-ce52-4caf-a5ef-8fa777aca739"], "spl_set_id": ["8373fced-93fe-44c6-93d9-8f21c6599f65"], "package_ndc": ["57237-119-01", "57237-119-99", "57237-119-90", "57237-120-99", "57237-120-90", "57237-120-01", "57237-121-99", "57237-121-90", "57237-121-01", "57237-122-99", "57237-122-90", "57237-122-01", "57237-123-99", "57237-123-90", "57237-123-01", "57237-124-99", "57237-124-90", "57237-124-01", "57237-125-99", "57237-125-90", "57237-125-01", "57237-126-99", "57237-126-90", "57237-126-01", "57237-127-99", "57237-127-90", "57237-127-01"], "is_original_packager": [true], "unii": ["6153CWM0CL"]}, "product_type": "Drugs", "event_id": "91713", "recalling_firm": "RISING PHARMACEUTICALS", "address_1": "2 Tower Center Blvd", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.", "recall_number": "D-0348-2023", "product_description": "Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01", "product_quantity": "12,216 bottles (100 count each)", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230215", "center_classification_date": "20230223", "termination_date": "20240614", "report_date": "20230301", "code_info": "Batch #: NB101596, Exp. 04/30/2023"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0583-2023", "product_description": "Ampicillin for Injection, USP 2g per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-223-41", "product_quantity": "45,160 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0216-2023", "product_description": "KETAMINE 50MG/ML (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221031@55", "more_code_info": ""}, {"status": "Ongoing", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Exela Pharma Sciences, LLC", "Civica"], "product_ndc": ["51754-5001", "51754-5011", "51754-5002", "51754-5012", "72572-740"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["807284", "1868486", "1923484", "2198792"], "spl_id": ["4da0ba66-756d-4b4d-8018-81ca16578ef1", "98efb401-5361-41ff-979a-6857768a144c"], "spl_set_id": ["e9698a4f-1a95-4f28-a945-e8009d1d6dd4", "a10fdfbc-94a0-49ab-b26c-de1df042bc89"], "package_ndc": ["51754-5001-5", "51754-5001-4", "51754-5011-4", "51754-5002-5", "51754-5012-4", "72572-740-20", "72572-740-25", "51754-5001-1", "72572-740-01"], "is_original_packager": [true], "unii": ["8MDF5V39QO"], "upc": ["0372572740258"]}, "product_type": "Drugs", "event_id": "93265", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0116-2024", "product_description": "8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1mEq/mL), a) 20x50 mL Single Dose Vials (Vial NDC 51754-5001-1; Carton NDC 51754-5001-5) and b) 25x50 mL Single Dose Vials (Vial NDC 51754-5001-1; Carton NDC 51754-5001-4), For Intravenous Use Only, RX Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645; ALSO LABELED 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1mEq/mL), c) 20x50 mL Single Dose Vials, (Vial NDC 72572-740-01; Carton NDC 72572-740-20), Rx Only, Mfd for: Civica, Inc., Lehi, Utah, 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645.", "product_quantity": "355,220 vials", "reason_for_recall": "Presence of Particulate Matter: Silicone", "recall_initiation_date": "20231018", "center_classification_date": "20231122", "report_date": "20231129", "code_info": "a) P0001429, EXP 11/30/2023 b) P0001900, P0001902, EXP 08/31/2024; P0001903, P0001909, P0001945, EXP 09/30/2024; P0002002, EXP 11/30/2024; P0002052, EXP 12/31/2024 c) P0001912, EXP 08/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "San Juan", "state": "PR", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M012"], "brand_name": ["G-SUPRESS DX"], "generic_name": ["DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE"], "manufacturer_name": ["KRAMER NOVIS"], "product_ndc": ["52083-655"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1095503"], "spl_id": ["240c105d-f172-cae0-e063-6394a90a9d85"], "spl_set_id": ["5dd44337-f3aa-4e73-a206-4a29850a2f7c"], "package_ndc": ["52083-655-01"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "92324", "recalling_firm": "Novis PR, LLC dba Kramer Novis", "address_1": "320 Ave Barbosa", "address_2": "N/A", "postal_code": "00917-4315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico", "recall_number": "D-0868-2023", "product_description": "G-Supress DX (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl) Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant, Cherry Flavor Sugar & Alcohol Free, packaged in a bottle Net Content: 30 mL (1 oz.) further packaged in a carton, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-655-01", "product_quantity": "9077 bottles", "reason_for_recall": "Product mix-up: incorrect product was found inside the G-Supress DX product carton.", "recall_initiation_date": "20230420", "center_classification_date": "20230606", "termination_date": "20240913", "report_date": "20230607", "code_info": "Lot: D20911, Exp. Oct/25"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["ALLERGY RELIEF"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["Meijer, Inc."], "product_ndc": ["79481-0847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["dfa09879-a814-421c-8ea8-09193bc1c09d"], "spl_set_id": ["deecbf76-be1d-4b27-85c6-17cfb7e7d1a1"], "package_ndc": ["79481-0847-1", "79481-0847-0", "79481-0847-2", "79481-0847-4", "79481-0847-3"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0906-2023", "product_description": "allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 79481-0847-0), b)30-count cartons (NDC 79481-0847-1), and c) 45-count cartons (NDC 79481-0847-2), Distributed by: MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544.", "product_quantity": "59,688 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: a) 2JE1882, Exp. date 01/24 b) 2FV1918, 2ER0411, Exp. date 01/24; 2GV1902, Exp. date 04/24; 2CR0652, 2DR0465, Exp. date 12/23; 2GR0329, Exp. date 04/24 c)2CR0653, 2DR0466, Exp. date 12/23; 2ER0287, 2ER0412, Exp. date 01/24", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017512"], "brand_name": ["DIANEAL LOW CALCIUM WITH DEXTROSE"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"], "manufacturer_name": ["Vantive US Healthcare LLC"], "product_ndc": ["0941-0409", "0941-0411", "0941-0413", "0941-0415", "0941-0457", "0941-0459", "0941-0426", "0941-0427", "0941-0429", "0941-0424", "0941-0430", "0941-0433", "0941-0484", "0941-0487", "0941-0490"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["799999", "800003", "800057", "800061", "800062", "800064", "800066", "800074", "800111", "800115", "800472", "800474"], "spl_id": ["36ea94f6-f614-9531-e063-6294a90aae55"], "spl_set_id": ["aa268d3f-7389-4f25-801f-5d4825495f08"], "package_ndc": ["0941-0411-05", "0941-0411-06", "0941-0411-07", "0941-0411-04", "0941-0411-11", "0941-0413-05", "0941-0413-06", "0941-0413-07", "0941-0413-01", "0941-0413-04", "0941-0415-05", "0941-0415-06", "0941-0415-04", "0941-0415-07", "0941-0415-01", "0941-0409-06", "0941-0409-05", "0941-0409-07", "0941-0409-01", "0941-0457-08", "0941-0457-02", "0941-0457-05", "0941-0457-01", "0941-0459-08", "0941-0459-02", "0941-0459-05", "0941-0459-01", "0941-0426-52", "0941-0426-53", "0941-0426-55", "0941-0427-52", "0941-0427-53", "0941-0427-55", "0941-0429-52", "0941-0429-53", "0941-0429-55", "0941-0424-51", "0941-0424-52", "0941-0424-53", "0941-0424-55", "0941-0430-51", "0941-0430-52", "0941-0430-53", "0941-0430-55", "0941-0433-51", "0941-0433-52", "0941-0433-53", "0941-0433-55", "0941-0484-01", "0941-0487-01", "0941-0490-01"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "92931", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1140-2023", "product_description": "DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution 1.5% Dextrose, packaged in a) 2000 mL AMBU-FLEX II Container bag, Product Code L5B4825, NDC 0941-0409-06; b) 5000 mL AMBU-FLEX II Container bag, Product Code L5B4826, NDC 0941-0409-07; and c) 6000 mL AMBU-FLEX II Container bag, Product Code L5B9770, NDC 0941-0409-01, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.", "product_quantity": "a) 44,520; b) 60,762; c) 483,912", "reason_for_recall": "Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.", "recall_initiation_date": "20230811", "center_classification_date": "20230829", "termination_date": "20240716", "report_date": "20230906", "code_info": "a) Lots Y403948, Exp 30-Sep-2024; Lot Y406277, Exp 31-Oct-2024.   b) Lot 408790, Exp 30-Nov-2024 and   c) Lots Y403740, Y403740A, Exp 30-Sep-2024; Lots Y405638, Y405805, Y407304, Y407304A Exp 31-Oct-2024; Lots Y407717, Y407717A, Y408554, Exp 30-Nov-2024; Lot Y420075, Exp 30-Apr-2025"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0275-2023", "product_description": "AMPICILLIN 8GM IN NS 400ML, antibiotic, used with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,", "product_quantity": "14 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 25-December 30, 2022"}, {"status": "Ongoing", "city": "Park City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91708", "recalling_firm": "Nutraceutical Corporation", "address_1": "1777 Sun Peak Dr", "address_2": "", "postal_code": "84098-6502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0439-2023", "product_description": "NaturalCare bioAllers, Mold, Yeast and Dust, Homeopathic, Liquid Drops, 20% Alcohol, 1 FL OZ( 30mL), Mfd. for Nutraceutical Corp. NaturalCare Park City, UT, 84098 USA", "product_quantity": "8,146", "reason_for_recall": "CGMP Deviations: Raw material recalled by repackager, due to discoloration.", "recall_initiation_date": "20230223", "center_classification_date": "20230307", "report_date": "20230315", "code_info": "Lot 222076, Exp: 03/27;", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0303-2023", "product_description": "MEROPENEM (a) 1000MG IN NS 250ML, (b) 2GM IN NS 100ML, (c) 500mg IN NS 125ML, antibiotic, Rx Only, use with home pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "91 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 24-31, 2022"}, {"status": "Ongoing", "city": "Ranasthalam Mandal, Srikakulam", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA076286"], "brand_name": ["TIZANIDINE"], "generic_name": ["TIZANIDINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-179", "55111-180"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TIZANIDINE HYDROCHLORIDE"], "rxcui": ["313412", "313413"], "spl_id": ["386ec98d-4a47-b025-b050-7e4ebce382c6"], "spl_set_id": ["a42f3479-f2c2-8214-d547-c5cae9bfed1e"], "package_ndc": ["55111-179-30", "55111-179-15", "55111-179-03", "55111-179-10", "55111-180-30", "55111-180-15", "55111-180-03", "55111-180-10"], "is_original_packager": [true], "upc": ["0355111180104", "0355111179108"], "unii": ["B53E3NMY5C"]}, "product_type": "Drugs", "event_id": "92564", "recalling_firm": "Dr Reddy's Laboratories Limited", "address_1": "Fto-Sez Unit 1, Surv. 57-59,60, 62 & 72", "address_2": "Sect. 9-14, 17-20, Devunipalavalasa", "postal_code": "N/A", "voluntary_mandated": "N/A", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0923-2023", "product_description": "Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10", "product_quantity": "17,548 1000-countbottles", "reason_for_recall": "Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.", "recall_initiation_date": "20230621", "center_classification_date": "20230717", "report_date": "20230726", "code_info": "Lot: T2100585, T2100586, T2100587, Exp 12/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Pearl River", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91576", "recalling_firm": "Urban Electric Power", "address_1": "401 N Middletown Rd Bldg 155", "address_2": "", "postal_code": "10965-1298", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0264-2023", "product_description": "Ohm Sanitizer Spray (alcohol (ethyl alcohol) 80% v/v, 8 FL OZ (237 ML) bottles.", "product_quantity": "609 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.", "recall_initiation_date": "20230117", "center_classification_date": "20230208", "termination_date": "20240226", "report_date": "20230215", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206251"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-278", "16729-279", "16729-280", "16729-281", "16729-282", "16729-283"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "402131", "602964"], "spl_id": ["40825d37-d601-2272-e063-6294a90af90d"], "spl_set_id": ["85cc7d25-414b-4b6f-a03a-48af908a16a1"], "package_ndc": ["16729-278-10", "16729-278-01", "16729-278-16", "16729-278-46", "16729-279-10", "16729-279-01", "16729-279-16", "16729-279-46", "16729-280-10", "16729-280-01", "16729-280-16", "16729-280-46", "16729-281-10", "16729-281-01", "16729-281-16", "16729-281-46", "16729-282-10", "16729-282-01", "16729-282-16", "16729-282-46", "16729-283-10", "16729-283-01", "16729-283-16", "16729-283-46"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"], "upc": ["316729280105", "316729280013"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0367-2023", "product_description": "Aripiprazole Tablets, USP 10 mg Rx Only, Packaged as a) 30-count bottle, NDC 16729-280-10, UPC 3 16729 28010 5; b) 100-count bottle, NDC 16729-280-01, UPC 3 16729 28001 3; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703.  Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. India", "product_quantity": "539,004 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a)P2006421, P2004882, P2004939, P2004883, P2004940, P2004942, P2004943, P2004944, Exp. Date 8/31/2023; P2107593, P2106907, P2106906, P2106908, P2106909, Exp. Date 10/31/2024;   b)P2102144, Exp. Date 3/31/2023; P2106903 Exp. Date 10/31/2023; P2204437, Exp. Date 7/31/2025;", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206977"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0105", "71858-0110", "71858-0112", "71858-0113", "71858-0115", "71858-0117", "71858-0120", "71858-0125", "71858-0130", "71858-0135", "71858-0140", "71858-0145", "71858-0150", "71858-0155", "71858-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["2056462", "2056466", "2056468", "2056470", "2056472", "2056474", "2056476", "2056478", "2056480", "2056482", "2056484", "2056486", "2056488", "2056490", "2056492", "2056494", "2056496", "2056498", "2056500", "2056502", "2056504", "2056506", "2056508", "2056510", "2566608", "2566610", "2566613", "2566615", "2566617", "2566619"], "spl_id": ["2c23d44e-1a15-f636-e063-6294a90a0ed4"], "spl_set_id": ["5d378add-f13d-40f2-99dc-0f2340ab44b7"], "package_ndc": ["71858-0105-6", "71858-0105-4", "71858-0105-5", "71858-0105-1", "71858-0105-2", "71858-0110-6", "71858-0110-4", "71858-0110-5", "71858-0110-1", "71858-0110-2", "71858-0112-6", "71858-0112-4", "71858-0112-5", "71858-0112-1", "71858-0112-2", "71858-0113-6", "71858-0113-4", "71858-0113-5", "71858-0113-1", "71858-0113-2", "71858-0115-6", "71858-0115-4", "71858-0115-5", "71858-0115-1", "71858-0115-2", "71858-0117-6", "71858-0117-4", "71858-0117-5", "71858-0117-1", "71858-0117-2", "71858-0120-6", "71858-0120-4", "71858-0120-5", "71858-0120-1", "71858-0120-2", "71858-0125-6", "71858-0125-4", "71858-0125-5", "71858-0125-1", "71858-0125-2", "71858-0130-6", "71858-0130-4", "71858-0130-5", "71858-0130-1", "71858-0130-2", "71858-0135-6", "71858-0135-4", "71858-0135-5", "71858-0135-1", "71858-0135-2", "71858-0140-6", "71858-0140-4", "71858-0140-5", "71858-0140-1", "71858-0140-2", "71858-0145-6", "71858-0145-4", "71858-0145-5", "71858-0145-1", "71858-0145-2", "71858-0150-6", "71858-0150-4", "71858-0150-5", "71858-0150-1", "71858-0150-2", "71858-0155-6", "71858-0155-4", "71858-0155-5", "71858-0155-1", "71858-0155-2", "71858-0160-6", "71858-0160-4", "71858-0160-5", "71858-0160-1", "71858-0160-2"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91556", "recalling_firm": "IBSA PHARMA INC", "address_1": "8 Campus Dr Ste 201", "address_2": "N/A", "postal_code": "07054-4409", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0340-2023", "product_description": "TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0120-5", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20230130", "center_classification_date": "20230404", "termination_date": "20231031", "report_date": "20230301", "code_info": "Lot #: 220853, Exp. 02/2024."}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA212287"], "brand_name": ["PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM"], "generic_name": ["PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "product_ndc": ["70594-078", "70594-079", "70594-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PIPERACILLIN SODIUM", "TAZOBACTAM SODIUM"], "rxcui": ["1659131", "1659137", "1659149"], "spl_id": ["b2fac277-0a3b-47ff-90ca-a0a5c8ad993f"], "spl_set_id": ["184b5961-1ae7-474c-afaa-2a2b2ccfc9cd"], "package_ndc": ["70594-078-01", "70594-078-02", "70594-079-01", "70594-079-02", "70594-080-01", "70594-080-02"], "is_original_packager": [true], "unii": ["M98T69Q7HP", "UXA545ABTT"]}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0629-2023", "product_description": "Piperacillin and Tazobactam for Injection, USP 2.25 g per vial,s Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-078-02", "product_quantity": "169,520 Vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0830-2023", "product_description": "Naloxone Injection, USP 0.4 mg/mL, For Intravenous, Intramuscular or Subcutaneous Use, 1 mL vials, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0596-2023", "product_description": "Ampicillin and Sulbactam for Injection, USP 1.5 grams per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-241-41", "product_quantity": "58,770 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0797-2023", "product_description": "Cromolyn Sodium Ophthalmic Solution, USP, 4%, 10 mL bottles, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0672-2023", "product_description": "Cardioplegia Solution, Induction 4:1 in Ringer's, HIGH POTASSIUM, 48 mEq K, packaged in 522.8 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0206-1.", "product_quantity": "333 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-894326, Exp 04/29/2023; 37-895212, Exp 05/04/2023; 37-896794, Exp 05/08/2023; 37-897286, Exp 05/12/2023; 37-899267, Exp 05/19/2023"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206977"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0105", "71858-0110", "71858-0112", "71858-0113", "71858-0115", "71858-0117", "71858-0120", "71858-0125", "71858-0130", "71858-0135", "71858-0140", "71858-0145", "71858-0150", "71858-0155", "71858-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["2056462", "2056466", "2056468", "2056470", "2056472", "2056474", "2056476", "2056478", "2056480", "2056482", "2056484", "2056486", "2056488", "2056490", "2056492", "2056494", "2056496", "2056498", "2056500", "2056502", "2056504", "2056506", "2056508", "2056510", "2566608", "2566610", "2566613", "2566615", "2566617", "2566619"], "spl_id": ["2c23d44e-1a15-f636-e063-6294a90a0ed4"], "spl_set_id": ["5d378add-f13d-40f2-99dc-0f2340ab44b7"], "package_ndc": ["71858-0105-6", "71858-0105-4", "71858-0105-5", "71858-0105-1", "71858-0105-2", "71858-0110-6", "71858-0110-4", "71858-0110-5", "71858-0110-1", "71858-0110-2", "71858-0112-6", "71858-0112-4", "71858-0112-5", "71858-0112-1", "71858-0112-2", "71858-0113-6", "71858-0113-4", "71858-0113-5", "71858-0113-1", "71858-0113-2", "71858-0115-6", "71858-0115-4", "71858-0115-5", "71858-0115-1", "71858-0115-2", "71858-0117-6", "71858-0117-4", "71858-0117-5", "71858-0117-1", "71858-0117-2", "71858-0120-6", "71858-0120-4", "71858-0120-5", "71858-0120-1", "71858-0120-2", "71858-0125-6", "71858-0125-4", "71858-0125-5", "71858-0125-1", "71858-0125-2", "71858-0130-6", "71858-0130-4", "71858-0130-5", "71858-0130-1", "71858-0130-2", "71858-0135-6", "71858-0135-4", "71858-0135-5", "71858-0135-1", "71858-0135-2", "71858-0140-6", "71858-0140-4", "71858-0140-5", "71858-0140-1", "71858-0140-2", "71858-0145-6", "71858-0145-4", "71858-0145-5", "71858-0145-1", "71858-0145-2", "71858-0150-6", "71858-0150-4", "71858-0150-5", "71858-0150-1", "71858-0150-2", "71858-0155-6", "71858-0155-4", "71858-0155-5", "71858-0155-1", "71858-0155-2", "71858-0160-6", "71858-0160-4", "71858-0160-5", "71858-0160-1", "71858-0160-2"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91556", "recalling_firm": "IBSA PHARMA INC", "address_1": "8 Campus Dr Ste 201", "address_2": "N/A", "postal_code": "07054-4409", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0344-2023", "product_description": "TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0150-5", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20230130", "center_classification_date": "20230404", "termination_date": "20231031", "report_date": "20230301", "code_info": "Lot #: 220959, Exp. 3/2024."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0151-2023", "product_description": "Olopatadine HCl Ophthalmic Solution, USP 0.1%, 5 mL per bottle, Rx Only, Manufactured by:  Akorn, Inc., Lake Forest, IL 60045. Marketed by: GSMS, Incorporated, Camarillo, CA 93012.  NDC:  60429-957-05", "product_quantity": "121,176 bottles", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: 1C61A, EXP 2/28/2023; 1D86A, 1D07A, EXP 3/31/2023;"}, {"status": "Completed", "city": "Irving", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91272", "recalling_firm": "NCH Life Sciences LLC", "address_1": "2730 Carl Rd", "address_2": "", "postal_code": "75062-6405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in United States and Canada.", "recall_number": "D-0092-2023", "product_description": "Alcohol Antiseptic 80% Topical Solution Hand Sanitizer, Non-Sterile Solution, packaged as a a) 2.5 gallon bottle (9,464 ml), NDC 55533-524-02, and b) 55 gallon bottle (208,198 ml), NDC 55533-524-03, Manufactured for: Multi-Mist Products A Division of NCH Corporation 1618 Northgate, Irving, Texas 75062", "product_quantity": "10,930 gallons", "reason_for_recall": "CGMP Deviations: Impurities of acetal and acetaldehyde were discovered in the product in excess of allowed limits.", "recall_initiation_date": "20221209", "center_classification_date": "20221228", "report_date": "20230104", "code_info": "Lots: 12032504, 12014282, 12013501, 12104039, 12013505, 12032523, 12013510, 12014804, 12015401, and 12014113", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0971-2023", "product_description": "vancomycin 750 mg/250 mL added to 0.9% Sodium Chloride, (3 mg/mL), IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6071-1", "product_quantity": "1927 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239990, Exp. 7/13/2023; 36-240839, Exp. 7/18/2023; 36-242706, Exp. 7/26/2023; 36-243952, Exp. 7/31/2023; 36-253889, Exp. 8/31/2023; 36-255691, Exp. 9/7/2023."}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0189-2023", "product_description": "Minoxidil 0.75% (1.5ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221011@36", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0740-2023", "product_description": "oxyTOCIN 40 units added to 0.9% sodium chloride 1,000 bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-8069-1.", "product_quantity": "2186 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-886265, Exp 05/11/2023; 37-886266, Exp 05/11/2023; 37-889903, Exp 05/25/2023; 37-890551, Exp 05/29/2023; 37-892521, 37-892620, Exp 06/06/2023; 37-896246, 37-896247, Exp 06/20/2023; 37-898553, Exp 06/29/2023"}, {"status": "Terminated", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91762", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States including VA or other Government facilities", "recall_number": "D-0442-2023", "product_description": "Phenylephrine HCl 0.5 mg per 5 mL (100 mcg/mL), 5 mL Syringe, Rx only, Leiters 13796 Compark Blvd Englewood CO 80112, NDC 71449-001-11", "product_quantity": "13,445 units", "reason_for_recall": "CGMP DEVIATIONS", "recall_initiation_date": "20230221", "center_classification_date": "20230307", "termination_date": "20240111", "report_date": "20230315", "code_info": "Lot #: 2230960, Exp date 3/12/2023; 2231080, Exp date 4/9/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0651-2023", "product_description": "Cardioplegia Solution, Reperfusate No Potassium, packaged in 477.5 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0006-1.", "product_quantity": "151 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-895691, Exp 05/05/2023; 37-896792, Exp 05/08/2023; 37-899170, Exp 05/19/2023"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078181"], "brand_name": ["GLIMEPIRIDE"], "generic_name": ["GLIMEPIRIDE"], "manufacturer_name": ["Accord Healthcare Inc"], "product_ndc": ["16729-001", "16729-002", "16729-003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLIMEPIRIDE"], "rxcui": ["199245", "199246", "199247"], "spl_id": ["415deb6c-47dc-ed2a-e063-6394a90a66fa"], "spl_set_id": ["9b74fbac-9e04-4927-9981-1e3dace89c6d"], "package_ndc": ["16729-001-01", "16729-001-16", "16729-001-17", "16729-002-01", "16729-002-16", "16729-002-17", "16729-003-01", "16729-003-16", "16729-003-17"], "is_original_packager": [true], "upc": ["0316729003018", "0316729002011", "316729001014", "316729001168"], "nui": ["N0000175608", "M0020795"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "unii": ["6KY687524K"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0393-2023", "product_description": "Glimepiride Tablets USP, 1 mg, Rx Only, Packaged in: a) 100-count bottle  NDC 16729-001-01 UPC 3 16729 00101 4; b) 500-count bottle NDC 16729-001-16 UPC 3 16729 00116 8; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "469,944 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) R2000166, Exp. Date 4/30/2023, P2003528 Exp. Date 6/30/2023, P2005451 Exp. Date 8/31/2023, P2005438 Exp. Date 8/31/2023, P2005436 Exp. Date 8/31/2023, P2005437 Exp. Date 8/31/2023, P2005452 Exp. Date 8/31/2023, P2006055 Exp. Date 9/30/2023, P2101782 Exp. Date 2/28/2024, P2101783 Exp. Date 2/28/2024, P2101781 Exp. Date 2/29/2024, P2102171 Exp. Date 2/29/2024, P2101844 Exp. Date 3/31/2024, P2101846 Exp. Date 3/31/2024, P2101845 Exp. Date 3/31/2024; b) P2006510 Exp. Date 11/30/2023, P2100975 Exp. Date 1/31/2024, P2100625 Exp. Date 1/31/2024, P2101778 Exp. Date 2/29/2024, P2101779 Exp. Date 2/29/2024, P2103021 Exp. Date 4/30/2024, P2103020 Exp. Date 4/30/2024, R2100657 Exp. Date 5/31/2024, R2100656 Exp. Date 5/31/2024, R2100658 Exp. Date 5/31/2024, P2104735 Exp. Date 7/31/2024, P2104739 Exp. Date 7/31/2024, P2104737 Exp. Date 7/31/2024, P2104738 Exp. Date 7/31/2024, P2106260 Exp. Date 9/30/2024, P2107384 Exp. Date 9/30/2024, R2200045 Exp. Date 12/31/2024, R2200046 Exp. Date 12/31/2024, R2200054 Exp. Date 12/31/2024, R2200055 Exp. Date 12/31/2024, R2200057 Exp. Date 12/31/2024, R2200058 Exp. Date 12/31/2024, R2200053 Exp. Date 12/31/2024, R2200059 Exp. Date 12/31/2024, R2200056 Exp. Date 12/31/2024, P2201929 Exp. Date 2/28/2025, R2200663 Exp. Date 4/30/2025, P2203518 Exp. Date 5/31/2025, R2200897 Exp. Date 6/30/2025, R2200898 Exp. Date 6/30/2025, R2200899 Exp. Date 6/30/2025, P2205528 Exp. Date 8/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91259", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings DBA Haleon", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0183-2023", "product_description": "Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5", "product_quantity": "209,292 capsules", "reason_for_recall": "Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back", "recall_initiation_date": "20221206", "center_classification_date": "20230125", "termination_date": "20240226", "report_date": "20230201", "code_info": "Lot: R93517, R94072, R94073, Exp 02/29/2024; T00655, Exp 03/31/2025", "more_code_info": ""}, {"status": "Completed", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92367", "recalling_firm": "Empower Clinic Services LLC dba Empower Pharmacy", "address_1": "5980 W Sam Houston Pkwy N Ste 300", "address_2": "", "postal_code": "77041-5251", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0865-2023", "product_description": "ASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY, Compounded by: Empower Pharmacy, 5980 W Sam Houston Pkwy N Ste 300 Houston, TX 77041, NDC 72627-2405-1", "product_quantity": "504 vials", "reason_for_recall": "Mislabeling: preservative free product labeled as preserved.", "recall_initiation_date": "20230512", "center_classification_date": "20230605", "report_date": "20230614", "code_info": "Lot: 606775 BUD: 09/25/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0196-2023", "product_description": "Buprenorphine HCL 0.9 MG/ML (25ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221118@33", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075356"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["60429-734", "60429-735", "60429-736", "60429-737"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["36f05340-73b3-a2dc-e063-6294a90a4f2c"], "spl_set_id": ["e63fe922-b35a-406c-8737-f3f5e6d5a30d"], "package_ndc": ["60429-734-30", "60429-734-90", "60429-734-10", "60429-735-30", "60429-735-90", "60429-735-10", "60429-736-30", "60429-736-90", "60429-736-10", "60429-737-30", "60429-737-90", "60429-737-10"], "original_packager_product_ndc": ["60505-0097", "60505-0083", "60505-0084", "60505-0101"], "unii": ["3I3T11UD2S"]}, "product_type": "Drugs", "event_id": "93431", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0130-2024", "product_description": "PAROXETINE  tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDC 60429-737-90; c)1000-count bottle, NDC 60429-737-10; Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, M9L 1T9, Packaged by GSMS, Incorporated, Camarillo, CA 93012.", "product_quantity": "5626 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine", "recall_initiation_date": "20231110", "center_classification_date": "20231130", "termination_date": "20250321", "report_date": "20231206", "code_info": "Lot #  a) GS036488, GS037091, GS037701, Exp. 08/31/2024; b) GS037090, GS037702, Exp. 08/31/2024; c) GS036677, GS037117, GS037699, Exp. 08/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92657", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "N/A", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0933-2023", "product_description": "Norepinephrine 16 mg per 250 mL (64 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per carton, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY  12903, NDC 70324-602-01.", "product_quantity": "92,148 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230707", "center_classification_date": "20230719", "termination_date": "20240708", "report_date": "20230726", "code_info": "Lot #: 490097, Exp 3-Aug-23; 490142, Exp 10-Aug-23; 491292, Exp 13-Aug-23; 494442, Exp 26-Nov-23; 496763, Exp 30-Nov-23; 496771, Exp 1-Dec-23; 497408, Exp 2-Dec-23; 497416, Exp 3-Dec-23; 499438, Exp 28-Jan-24; 501032, Exp 8-Feb-24; 501059, Exp 15-Feb-24; 502043, Exp 28-Mar-24; 502051, Exp 31-Mar-24; 503505, Exp 4-Apr-24; 504031, Exp 7-Apr-24; 504250, Exp 19-Apr-24", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040765"], "brand_name": ["EXTENDED PHENYTOIN SODIUM"], "generic_name": ["PHENYTOIN SODIUM"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENYTOIN SODIUM"], "rxcui": ["855671"], "spl_id": ["2b4f7d43-b5df-46e4-9cb9-216b70a360a0"], "spl_set_id": ["7e467c02-49a0-4b62-b537-430fdfa4f10e"], "package_ndc": ["65162-212-03", "65162-212-10", "65162-212-50", "65162-212-11"], "is_original_packager": [true], "upc": ["0365162212037", "0365162212105"], "unii": ["4182431BJH"]}, "product_type": "Drugs", "event_id": "93292", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0090-2024", "product_description": "Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10", "product_quantity": "9,263 100-count bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20231027", "center_classification_date": "20231107", "termination_date": "20250806", "report_date": "20231115", "code_info": "Lot # HM03221A, Exp. date 12/31/2023", "more_code_info": ""}, {"status": "Completed", "city": "Norwalk", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92857", "recalling_firm": "Ecometics, Inc.", "address_1": "19 Concord St", "address_2": "N/A", "postal_code": "06854-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1101-2023", "product_description": "AstrinGyn (Ferric Subsulfate) Aqueous, 259 mg/g, 8 gm Single Use Vials, Manufactured for CooperSurgical, Trumbull, CT 06611, NDC 59365-6065-0, Ref 6065.", "product_quantity": "92,967 vials", "reason_for_recall": "CGMP Deviations: Products not manufactured under current good manufacturing practices.", "recall_initiation_date": "20230809", "center_classification_date": "20230824", "report_date": "20230830", "code_info": "Lot #: 2E144A, 2E157A, exp: 11/2023; 2E270A, exp: 3/2024; 2E300A, exp: 4/2024"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0304-2023", "product_description": "METHADONE (a) 2.5MG IN 5ML NS SYRINGE, (b) 4MG IN 5ML NS SYRINGE, pain, Rx Only,  Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "19 syringes", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 28-29, 2022"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0812-2023", "product_description": "IC-Green (indocyanine green for injection, USP) 25 mg/10 mL Kit, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0009-2024", "product_description": "fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2071-1", "product_quantity": "1,767 3 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275621, Exp. 10/8/2023; 17-275693, 17-275725, Exp. 10/9/2023"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0746-2023", "product_description": "heparin added to 0.9% sodium chloride, 2,500 units/500 mL* (5 units/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-8100-1.", "product_quantity": "2992 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-888833, Exp 05/02/2023; 37-890537, Exp 05/09/2023; 37-892161, 37-892163, Exp 05/16/2023; 37-893979, 37-893992, Exp 05/23/2023; 37-895755, 37-895758, Exp 05/30/2023"}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1151-2023", "product_description": "TRP Natural Eyes, Aging Eye Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-027-15.", "product_quantity": "8,747 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot#:DB001 EXP: 06/24", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0317-2023", "product_description": "TOBRAMYCIN 660MG IN NS 66ML, antibiotic, Rx Only, use with homepump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,", "product_quantity": "2 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date, ecember 24, 2022"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0754-2023", "product_description": "HyperLyte CR  Injection, 500 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-8094-1, code 7128580941.", "product_quantity": "554 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-874236, Exp 06/20/2023; 37-878694, Exp 07/10/2023"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0857-2023", "product_description": "Amantadine Hydrochloride Oral Solution USP, 50mg/5mL, 473mL bottles, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0714-2023", "product_description": "norepinephrine 4 mg added to dextrose 5% 250 mL*, 16 mcg/mL, 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6056-1.", "product_quantity": "2041 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-884760, Exp 05/05/2023; 37-885601, Exp 05/09/2023; 37-887668, Exp 05/17/2023; 37-889594, Exp 05/24/2023; 37-892622, Exp 06/06/2023; 37-894316, Exp 06/13/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1079-2023", "product_description": "fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2071-1", "product_quantity": "6,770 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270539, Exp. 7/16/2023; 17-270981, Exp. 7/23/2023; 17-271167, Exp. 7/25/2023; 17-271337, Exp. 7/27/2023; 17-271827, Exp. 8/6/2023; 17-272214, Exp. 8/13/2023; 17-272536, 17-272555, Exp. 8/17/2023; 17-273424, 17-273432, Exp. 9/3/2023; 17-273476, Exp. 9/4/2023; 17-273882, Exp. 9/10/2023; 17-274044, Exp. 9/12/2023."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0861-2023", "product_description": "Pilocarpine Hydrochloride Ophthalmic Solution, USP 2%, 15 mL bottles, Rx Only, Sterile, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91749", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0359-2023", "product_description": "Phenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x 10 mL Sterile Single-Dose Vials per carton, 12 x 30 Vials Carton per case, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-302-10.", "product_quantity": "546,450 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230222", "center_classification_date": "20230227", "termination_date": "20240924", "report_date": "20230308", "code_info": "Lots: PE2025, Exp. 05/28/2023; PE2026, Exp. 06/02/2023; PE2027, Exp. 06/04/2023; PE2030, Exp. 06/29/2023; PE2031, Exp. 06/27/2023; PE2032, Exp. 07/09/2023; PE2032A, Exp. 07/09/2023; PE2033, Exp. 08/03/2023; PE2034, Exp. 08/31/2023; PE2035, Exp. 09/11/2023", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0278-2023", "product_description": "CEFAZOLIN (a) 12GM IN NS 600ML, (b) 2GM IN NS 100ML, (c) 2GM/20ML SW SYRINGE, (d) 3GM IN NS 150ML, antibiotic, used with a curlin, home or no pump assigned. Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "111 bags total 21 syringes total", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use By: December 25-31, 2022"}, {"status": "Completed", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M001"], "brand_name": ["TUMS"], "generic_name": ["CALCIUM CARBONATE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0135-0118", "0135-0180", "0135-0181", "0135-0228", "0135-0540"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CALCIUM CARBONATE"], "rxcui": ["308892", "1044524"], "spl_id": ["35c4dd66-0a1f-dda3-e063-6394a90a2c78"], "spl_set_id": ["f4786707-a0f7-4ba8-9656-06278d1b4b6c"], "package_ndc": ["0135-0118-01", "0135-0118-04", "0135-0118-14", "0135-0118-83", "0135-0180-01", "0135-0180-02", "0135-0180-14", "0135-0181-01", "0135-0181-02", "0135-0181-03", "0135-0181-05", "0135-0181-06", "0135-0181-07", "0135-0181-14", "0135-0228-01", "0135-0228-04", "0135-0228-05", "0135-0228-06", "0135-0228-07", "0135-0540-01", "0766-0746-80"], "is_original_packager": [true], "unii": ["H0G9379FGK"], "upc": ["307660746805"]}, "product_type": "Drugs", "event_id": "93255", "recalling_firm": "GlaxoSmithKline  Consumer Healthcare Holdings LLC", "address_1": "320 S Broadway", "address_2": "N/A", "postal_code": "63102-2800", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0074-2024", "product_description": "TUMS Antacid, Calcium Carbonate USP 1000 mg, Peppermint flavor, chewable tablets, packaged in 12-count roll, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0228-01, UPC 3-0766-0746-80-5", "product_quantity": "N/A", "reason_for_recall": "Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.", "recall_initiation_date": "20221202", "center_classification_date": "20231027", "report_date": "20231108", "code_info": "Lot #: HA7G, Exp. Date 8/31/2027"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1080-2023", "product_description": "morphine in 0.9% Sodium Chloride, 50 mg/50 mL (1mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2040-4", "product_quantity": "1,235 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-273353, Exp 8/31/2023, 17-270602, Exp 7/17/2023; 17-270706, Exp 7/18/2023; 17-271416, Exp 7/30/2023; 17-272049, Exp 8/9/2023; 17-272277, Exp 8/14/2023; 17-273231, Exp 8/30/2023."}, {"status": "Ongoing", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91707", "recalling_firm": "Pharmedica USA, LLC", "address_1": "2836 W Deer Valley Rd Bldg E2", "address_2": "", "postal_code": "85027-2300", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Worldwide through e-commerce and trade shows", "recall_number": "D-0456-2023", "product_description": "Purely Soothing 15% MSM Drops, packaged in a)15 ml, .5 fl oz bottle, UPC 7 31034 91382 9; and b) 30 ml, 1.014 fl oz bottle, UPC 7 31034 91379 9; Manufactured by: Pharmedica USA, Phoenix, AZ.", "product_quantity": "a) 869 bottles; b) 1035 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20230214", "center_classification_date": "20230310", "report_date": "20230315", "code_info": "Lot #s: a) 1808051, Exp.: 01/01/2027; b) 2203PS01, Exp.: 01/01/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0120-2023", "product_description": "QuadMix Injectable (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 20mcg/20mg/2mg/0.2mg/mL INJECTABLE, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11292022@12, Exp 1/13/2023", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0020-2024", "product_description": "fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2", "product_quantity": "174, 5 mL syringes.", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275479, Exp. 10/4/2023; 17-275852, Exp. 10/11/2023"}, {"status": "Completed", "city": "Ann Arbor", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA211617"], "brand_name": ["NEXLIZET"], "generic_name": ["BEMPEDOIC ACID AND EZETIMIBE"], "manufacturer_name": ["Esperion Therapeutics, Inc."], "product_ndc": ["72426-818"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BEMPEDOIC ACID", "EZETIMIBE"], "spl_id": ["ded66e40-dc19-4b24-ad70-cdcafb34d901"], "spl_set_id": ["3fa2108c-0300-47b8-9d34-f762af7c93c6"], "package_ndc": ["72426-818-03", "72426-818-09", "72426-818-99"], "is_original_packager": [true], "nui": ["N0000193913", "N0000193914", "N0000008553", "N0000175911"], "pharm_class_epc": ["Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["1EJ6Z6Q368", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "92897", "recalling_firm": "Esperion", "address_1": "3891 Ranchero Dr Ste 150", "address_2": "N/A", "postal_code": "48108-2837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1143-2023", "product_description": "Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03", "product_quantity": "45,240 bottles", "reason_for_recall": "Failed dissolution specifications: below specification results at stability 12-month", "recall_initiation_date": "20230816", "center_classification_date": "20230906", "report_date": "20230913", "code_info": "Lot# 1904872, Exp 1/31/2025; 1950377, Exp 6/30/2025"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0903-2023", "product_description": "Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Distributed By: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 69842-0914-39", "product_quantity": "16,200 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: 2DV1925, Exp. date 06/23", "more_code_info": ""}, {"status": "Terminated", "city": "Tonawanda", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93154", "recalling_firm": "Pine Pharmaceuticals, LLC", "address_1": "355 Riverwalk Pkwy", "address_2": "N/A", "postal_code": "14150-5837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0060-2024", "product_description": "TPC Drops (tropicamide 1%- phenylephrine 2.5%- cyclopentolate HCl 1% ophthalmic solution, 5 mL droppers, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.", "product_quantity": "1693 droppers", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231002", "center_classification_date": "20231019", "termination_date": "20240515", "report_date": "20231025", "code_info": "Lot #: 68184, Exp. Date 10/9/2023; 68623, Exp. Date 11/2/2023"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0199-2023", "product_description": "Clindamycin/EDTA Calcium 4.1667MG/0.333MG/ML (30ML syringe) Irrigation, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221109@41", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA212287"], "brand_name": ["PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM"], "generic_name": ["PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "product_ndc": ["70594-078", "70594-079", "70594-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PIPERACILLIN SODIUM", "TAZOBACTAM SODIUM"], "rxcui": ["1659131", "1659137", "1659149"], "spl_id": ["b2fac277-0a3b-47ff-90ca-a0a5c8ad993f"], "spl_set_id": ["184b5961-1ae7-474c-afaa-2a2b2ccfc9cd"], "package_ndc": ["70594-078-01", "70594-078-02", "70594-079-01", "70594-079-02", "70594-080-01", "70594-080-02"], "is_original_packager": [true], "unii": ["M98T69Q7HP", "UXA545ABTT"]}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0631-2023", "product_description": "Piperacillin and Tazobactam for Injection, USP, 4.5 grams per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-080-02", "product_quantity": "393,930 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92121", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS only", "recall_number": "D-0538-2023", "product_description": "C-Semaglutide 5mg/mL injection,  0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402", "product_quantity": "45 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20230413", "center_classification_date": "20230419", "report_date": "20230426", "code_info": "Lot #: 73810, Exp. Date 5/1/2023"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0658-2023", "product_description": "Cardioplegia Solution, Induction 4:1, High Potassium, 60 mEq K, packaged in 830 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0100-1.", "product_quantity": "267 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-894304, Exp 04/29/2023; 37-894946, Exp 05/01/2023; 37-896482, Exp 05/07/2023; 37-897933, Exp 05/13/2023; 37-900461, Exp 05/22/2023"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0225-2023", "product_description": "NADH 10MG/ML (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221108@46", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0819-2023", "product_description": "Levofloxacin Oral Solution, 25 mg/mL, packaged in a) 100 mL bottles, b) 200 mL bottles, and c) 480 mL bottles, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0236-2023", "product_description": "SEMAGLUTIDE 0.5MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 1MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 2MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 4MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 5.4MG/ML (0.5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221026@52 t20221102@11 t20221004@44 t20221116@36 t20221011@36", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0015-2024", "product_description": "fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2", "product_quantity": "895 50 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275165, 17-275166, Exp. 10/1/2023; 17-275217, Exp. 10/2/2023; 17-275715, Exp. 10/9/2023; 17-276035, Exp. 10/16/2023; 17-276112, Exp. 10/17/2023"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA209196"], "brand_name": ["ADMELOG"], "generic_name": ["INSULIN LISPRO"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "product_ndc": ["0024-5924", "0024-5925", "0024-5926"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["INSULIN LISPRO"], "rxcui": ["242120", "1652639", "1992169", "1992171"], "spl_id": ["9631cc90-ea8d-42bb-ba01-ed8f09b8a6c5"], "spl_set_id": ["0691def8-4a7b-4de3-866f-a280989f47f1"], "package_ndc": ["0024-5924-10", "0024-5925-01", "0024-5925-05", "0024-5925-00", "0024-5926-05"], "is_original_packager": [true], "nui": ["N0000004931", "N0000175453"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["GFX7QIS1II"]}, "product_type": "Drugs", "event_id": "92074", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "N/A", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0575-2023", "product_description": "Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05", "product_quantity": "51,325 vials", "reason_for_recall": "Lack of Assurance of Sterility: Malformed crimped collar seal", "recall_initiation_date": "20230411", "center_classification_date": "20230515", "report_date": "20230524", "code_info": "Lot # 3F497B, EXP 12-31-2025"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0664-2023", "product_description": "Cardioplegia Solution, Induction 4:1 High Potassium, 30 mEq K, packaged in 415 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0106-1.", "product_quantity": "84 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-894307, Exp 04/29/2023; 37-896158, Exp 05/06/2023; 37-898281, Exp 05/14/2023; 37-900321, Exp 05/22/2023"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0599-2023", "product_description": "Ampicillin and Sulbactam for Injection, USP 15 grams per Pharmacy Bulk Package, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-243-15", "product_quantity": "6,127 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0200-2023", "product_description": "Cyclosporine (A) 0.1%; Cyclosporine (A) 0.2%; Cyclosporine (A) 1%; Cyclosporine (A) 2%; Cyclosporine (A) - Corn oil - 1% Oph solution, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221109@43 t20221108@27 t20221011@41 t20221024@3 t20221104@37 t20221025@32 t20221025@33 t20221013@15 t20221017@5", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0002-2024", "product_description": "ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-3022-1", "product_quantity": "4,775 5 mL Syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275224, 17-275225, 17-275233, 17-275235, 17-275253, 17-275259, 17-275263, 17-275267 Exp. 10/2/2023; 17-275340, Exp. 10/3/2023; 17-275512, Exp. 10/5/2023; 17-275633, 17-275657, Exp. 10/8/2023."}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0881-2023", "product_description": "Arnica 7 Cream, net wt 2 oz (56.7g), Manufactured for: Brazmedics, LLC, New York, NY 10021 UPC 8 60208 00181 6", "product_quantity": "2,376 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot # 2446, exp. Mar-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92248", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0565-2023", "product_description": "Advil Dual Action with Acetaminophen Acetaminophen 250 mg and Ibuprofen (NSAID) 125 mg Tablets Pain Reliever,  36 Caplets bottles", "product_quantity": "", "reason_for_recall": "CGMP deviation: product outside labeled storage temperature requirements.", "recall_initiation_date": "20230331", "center_classification_date": "20230504", "report_date": "20230510", "code_info": "SKUs 0902867 stored and distributed from DCs 07/28/2022 through 03/31/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0702-2023", "product_description": "oxyTOCIN 20 units added to dextrose 5%/Lactated Ringer's 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6031-1.", "product_quantity": "7595 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883206, 37-883207, 37-883210, 37-883213, 37-883216, 37-883217, 37-883217, Exp 04/30/2023; 37-884447, 37-884450, Exp 05/04/2023; 37-886269, Exp 05/11/2023; 37-887516, Exp 05/16/2023; 37-888306, 37-888308, 37-888310, 37-888311, Exp 05/21/2023; 37-890097, 37-890099, 37-890101, 37-890108, Exp 05/28/2023; 37-892636, 37-892637, 37-892639, 37-892640, Exp 06/06/2023; 37-894451, 37-894452, 37-894476, 37-894482, Exp 06/13/2023; 37-895311, 37-895312, 37-895313, Exp 06/18/2023; 37-895804, Exp 06/19/2023; 37-896607, Exp 06/21/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0026-2024", "product_description": "succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6011-2", "product_quantity": "3,590 10 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275343, Exp. 10/3/2023; 17-275472, 17-275489, Exp.10/4/2023; 17-275876, Exp. 10/11/2023; 17-275976, 17-275985, Exp. 10/15/2023; 17-276204, Exp. 10/18/2023."}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206251"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-278", "16729-279", "16729-280", "16729-281", "16729-282", "16729-283"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "402131", "602964"], "spl_id": ["40825d37-d601-2272-e063-6294a90af90d"], "spl_set_id": ["85cc7d25-414b-4b6f-a03a-48af908a16a1"], "package_ndc": ["16729-278-10", "16729-278-01", "16729-278-16", "16729-278-46", "16729-279-10", "16729-279-01", "16729-279-16", "16729-279-46", "16729-280-10", "16729-280-01", "16729-280-16", "16729-280-46", "16729-281-10", "16729-281-01", "16729-281-16", "16729-281-46", "16729-282-10", "16729-282-01", "16729-282-16", "16729-282-46", "16729-283-10", "16729-283-01", "16729-283-16", "16729-283-46"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"], "upc": ["316729281102", "316729281010"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0368-2023", "product_description": "Aripiprazole Tablets, USP 15 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-281-10, UPC 3 16729 28110 2; b) 100-count bottle NDC 16729-281-01, UPC 3 16729 28101 0; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703.  Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. India", "product_quantity": "312,864 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2004997, P2004998, P2004999, Exp. Date 8/31/2023; P2101206, Exp. Date 1/31/2024 , P2102486, Exp. Date 4/30/2024; P2106247, P2105375, Exp. Date 7/31/2024; P2107239, P2107240, Exp. Date 10/31/2024;   b) P2204222 Exp. Date 7/31/2025, P2105374 Exp. 7/31/2024, P2203449 Exp. 5/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Charlottesville", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93150", "recalling_firm": "Biomic Sciences, LLC dba ION Intelligence of Nature", "address_1": "4351 Seminole Trl", "address_2": "N/A", "postal_code": "22911-8225", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the United States and to Canada, New Zealand, Australia, Indonesia, Malaysia, Great Britain, and the Netherlands", "recall_number": "D-0069-2024", "product_description": "Restore Sinus Spray, Manufactured by: Biomic Sciences, LLC Charlottesville, VA", "product_quantity": "N/A", "reason_for_recall": "Microbial contamination of Non-Sterile Products", "recall_initiation_date": "20230929", "center_classification_date": "20231024", "termination_date": "20240710", "report_date": "20231101", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208004"], "brand_name": ["FINGOLIMOD"], "generic_name": ["FINGOLIMOD HYDROCHLORIDE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-476"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FINGOLIMOD HYDROCHLORIDE"], "rxcui": ["1012895"], "spl_id": ["022f1ebe-0d03-4ba1-853e-91f1e81ed59b"], "spl_set_id": ["0f638feb-6986-41e4-8f9c-2e6b84a5bb44"], "package_ndc": ["67877-476-56", "67877-476-33", "67877-476-32", "67877-476-14", "67877-476-58", "67877-476-30"], "is_original_packager": [true], "unii": ["G926EC510T"]}, "product_type": "Drugs", "event_id": "92667", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0925-2023", "product_description": "Fingolimod Capsules, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ  07054, NDC 67877-476-30.", "product_quantity": "2652 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20230711", "center_classification_date": "20230718", "report_date": "20230726", "code_info": "Lot 22122841, Exp August 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1030-2023", "product_description": "CARDIOPLEGIA SOLUTION 122 mEq K, Modified St. Thomas Formula High Potassium, Total Volume = 1000 mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0209-1", "product_quantity": "80 bags.", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot:36-256332, Exp. 7/29/2023."}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1157-2023", "product_description": "TRP Natural Eyes, Eye Lid Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-417-19.", "product_quantity": "8,000 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: FV005 EXP:03/25", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1031-2023", "product_description": "CARDIOPLEGIA SOLUTION, 100 mEq K, Induction 8:1, High Potassium / Low dextrose, IV Bag, total volume = 500 mL, RX Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0107-1", "product_quantity": "284", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-252356, Exp. 7/17/2023; 36-254402, Exp. 7/21/2023; 36-255218, Exp. 7/23/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0029-2024", "product_description": "HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2011-1", "product_quantity": "4,550 30 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275315, Exp.10/3/2023; 17-275466, 17-275477, Exp.10/4/2023; 17-276102, Exp. 10/17/2023; 17-276221, Exp. 10/19/2023"}, {"status": "Terminated", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA200651"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6823", "0904-7108"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310433", "310434"], "spl_id": ["627db7ba-f2d2-476a-9bf9-918ee0b047d2"], "spl_set_id": ["152adf1d-ec0c-4561-bf80-e4c7da158723"], "package_ndc": ["0904-6823-61", "0904-7108-61"], "original_packager_product_ndc": ["65862-523", "65862-524"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "92174", "recalling_firm": "The Harvard Drug Group", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0570-2023", "product_description": "Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61", "product_quantity": "3984 cartons", "reason_for_recall": "Product mixup: one foreign tablet found in product.", "recall_initiation_date": "20230424", "center_classification_date": "20230510", "termination_date": "20240430", "report_date": "20230517", "code_info": "Lot: T04468, Exp 10/2024"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0018-2024", "product_description": "midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1", "product_quantity": "419 50 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275475, Exp. 10/4/2023; 17-276117, Exp. 10/17/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0963-2023", "product_description": "PHENYLephrine, 40mg/250ml, added to 0.9% sodium chloride, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6092-1.", "product_quantity": "9,432 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-240803, Exp. 7/17/2023; 36-241149, Exp. 7/19/2023; 36-241912, Exp. 7/23/2023; 36-243527, 36-243529, Exp. 7/30/2023; 36-244889, 36-244890, 36-244891, Exp. 8/1/2023; 36-246709, 36-246710, 36-246711, 36-246712, Exp. 8/6/2023; 36-247014, Exp. 8/7/2023; 36-247611, 36-247614, 36-247616, 36-247629, 36-247631, 36-247640, Exp. 8/9/2023; 36-248282, 36-248283, 36-248285, Exp. 8/13/2023; 36-249217, 36-249219, 36-249221, 36-249223, Exp. 8/17/2023; 36-251389, 36-251390, 36-251391, Exp. 8/27/2023; 36-251512, Exp. 8/28/2023; 36-251971, 36-251973, Exp. 8/30/2023; 36-252468, Exp. 9/3/2023"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0613-2023", "product_description": "Ceftriaxone for Injection, USP 1 gram per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017, NDC 66794-213-42", "product_quantity": "73,475 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Glasgow", "state": "KY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075022"], "brand_name": ["BUSPIRONE HYDROCHLORIDE"], "generic_name": ["BUSPIRONE HYDROCHLORIDE"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"], "product_ndc": ["0615-7689", "0615-7714", "0615-7718"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUSPIRONE HYDROCHLORIDE"], "rxcui": ["866018", "866083", "866094"], "spl_id": ["77cbe6b7-dd55-4745-a49e-1e22072beccd"], "spl_set_id": ["72bff09c-826e-4394-a7e7-41d56ce9605b"], "package_ndc": ["0615-7714-39", "0615-7714-05", "0615-7714-30", "0615-7718-39", "0615-7718-31", "0615-7718-05", "0615-7718-28", "0615-7689-39", "0615-7689-31", "0615-7689-05"], "original_packager_product_ndc": ["0093-0053", "0093-0054", "0093-1003"], "unii": ["207LT9J9OC"]}, "product_type": "Drugs", "event_id": "93336", "recalling_firm": "NCS Healthcare of Kentucky Inc", "address_1": "120 Carroll Knicely Dr", "address_2": "N/A", "postal_code": "42141-7224", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0113-2024", "product_description": "Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.", "product_quantity": "1,344 cards", "reason_for_recall": "Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots", "recall_initiation_date": "20231027", "center_classification_date": "20231121", "termination_date": "20240714", "report_date": "20231129", "code_info": "Lot#: a) 7718-3008, Exp 08/31/2024; b) 7718-3008, Exp 08/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0701-2023", "product_description": "EPINEPHrine added to dextrose 5%, 2 mg/250 mL* (8 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6030-1.", "product_quantity": "3338 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-884448, Exp 05/04/2023; 37-887386, Exp 05/16/2023; 37-888271, Exp 05/21/2023; 37-891189, Exp 05/31/2023; 37-893456, Exp 06/11/2023; 37-894656, Exp 06/14/2023; 37-898333, Exp 06/28/2023; 37-898559, Exp 06/29/2023"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078155"], "brand_name": ["SIMVASTATIN"], "generic_name": ["SIMVASTATIN"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-004", "16729-005", "16729-006", "16729-007", "16729-156"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIMVASTATIN"], "rxcui": ["198211", "200345", "312961", "312962", "314231"], "spl_id": ["1d86e518-c8d2-f3a7-e063-6394a90ab551"], "spl_set_id": ["871251c0-36a1-4a32-9eab-ff6c1e925ca9"], "package_ndc": ["16729-005-10", "16729-005-12", "16729-005-15", "16729-005-17", "16729-006-10", "16729-006-12", "16729-006-15", "16729-006-17", "16729-007-10", "16729-007-12", "16729-007-15", "16729-007-17", "16729-156-10", "16729-156-15", "16729-156-17", "16729-004-10", "16729-004-12", "16729-004-15", "16729-004-17"], "is_original_packager": [true], "nui": ["N0000175589", "N0000000121"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "unii": ["AGG2FN16EV"], "upc": ["316729006156", "316729006170"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0411-2023", "product_description": "Simvastatin Tablets USP 40 mg Rx Only, Packaged as: a) 90-count tablets NDC 16729-006-15,  UPC 3 16729 00615 6; b) 1,000-count tablets NDC 16729-006-17, UPC 3 16729 00617 0; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA", "product_quantity": "1,190,484 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2103713, P2103692, Exp. Date 5/31/2023, P2104950, P2104984, P2104969, P2104996, P2105274, P2105314, P2105316, Exp. Date 7/31/2023, R2101074, R2101077, R2101078, R2101079, R2101083, R2101084, R2101117, Exp. Date 8/31/2023, R2101330, R2101331, R2101335, R2101336, R2101334, R2101337, R2101339, Exp. Date 9/30/2023, R2101494, R2101495, R2101496, R2101497, Exp. Date 10/31/2023, R2200527, R2200531, Exp. Date 3/31/2024, R2200606, R2200625, Exp. Date 4/30/2024;   b) P2101911, P2101913, R2100344, R2100351, R2100354, R2100346, R2100357, R2100358, R2100359, R2100361, R2100362, R2100385, R2100386, R2100388, R2100394, R2100397, R2100345, Exp. Date 2/28/2023; P2101930, P2101983, R2100435, R2100457, R2100433, R2100462, R2100466, R2100465, R2100469, R2100468, Exp. Date 3/31/2023; P2103223, P2103229, P2103234, Exp. Date 4/30/2023; P2103254, P2103258, P2103261, P2103323, P2103362, P2103364, P2103310, P2103671, P2103678, P2103545, P2103568, P2103599, P2103616, P2103627, P2103649, P2103813, P2103832, P2103834, P2103867, P2103868, P2103901, P2103912, Exp. Date 5/31/2023; P2105024, P2105027, P2105028, P2105049, P2105047, P2105052, P2105340, P2105341, P2105420, P2105432, P2105445, P2105455, P2105456, P2105467, P2105461, Exp. Date 7/31/2024; R2101118, R2101119, R2101127, R2101128, R2101134, R2101145, R2101133, R2101146, R2101149, R2101164, R2101169, R2101165, R2101187, R2101188, R2101192, R2101193, R2101168, R2101194, Exp. Date 8/31/2024; R2101516, R2101517, R2101515, R2101523, R2101525, R2101524, R2101530, R2101531, R2101532, R2101534, R2101533, R2101541, R2101547, R2101569, R2101567, R2101568, R2101571, R2101580, R2101582, R2101592, R2101583, R2101581, R2101593, P2107446, Exp. Date 10/31/2024; P2107791, P2107792, Exp. Date 11/30/2024; R2200271, R2200272, R2200275, Exp. Date 1/31/2025; R2200374, R2200379, R2200378, R2200391, Exp. Date 2/28/2025; R2200457, R2200458, R2200540, R2200470, R2200541, R2200459, R2200451, R2200471, Exp. Date 3/31/2025; R2200610, R2200611, R2200616, R2200615,R2200624, R2200628, R2200736, Exp. Date 4/30/2025, R2200688, R2200681, R2200687, Exp. Date 5/31/2025;", "more_code_info": ""}]